Analysis Shows U.S. Foreign Aid Under Trump Administration Directed More Funds to U.S.-Based Contractors
A new analysis indicates that the Trump administration's overhaul of foreign aid programs allocated millions more dollars to large U.S.-based contractors. Organizations in developing countries received nearly no funding during this period. The changes affected aid distribution, including programs in locations such as Borno, Nigeria, where U.S.-based nonprofits operated outpatient services.
Substrate placeholder — needs reviewThe Trump administration implemented changes to U.S. foreign aid programs that resulted in increased funding for large contractors based in the United States, according to a new analysis. These contractors, including major aid agencies, received substantial infusions of cash.
In contrast, organizations located in developing countries were allocated nearly no funds under the revised system. The analysis highlights how the overhaul prioritized U.S.-based entities in the distribution of aid dollars. This shift occurred amid broader efforts to restructure foreign assistance, focusing on efficiency and alignment with administration priorities.
The Department of Government Efficiency (DOGE), referenced in prior discussions, had identified certain aid agencies as inefficient, though the analysis does not detail specific DOGE actions in the funding decisions.
An example of the aid programs involved is an outpatient therapeutic program in Borno, Nigeria, operated by FHI360, a nonprofit organization based in North Carolina. Women and children in the region waited to receive nutrition treatment and therapeutic food at this facility.
Such programs demonstrate how U.S.-based contractors continued to deliver services on the ground despite the funding shifts. The analysis, conducted by an independent entity, examined financial data from the period of the overhaul. It found that millions of additional dollars flowed to big U.S.-based contractors, while local organizations in recipient countries faced significant reductions.
This pattern raises questions about the long-term effectiveness of aid delivery, though the report focuses on factual allocations rather than outcomes.
aid constitutes a key component of U.S. international engagement, supporting health, nutrition, and development initiatives worldwide. The Trump administration's changes, enacted during its term, aimed to streamline spending but led to concentrated funding among fewer, larger recipients.
Stakeholders affected include communities in developing nations reliant on local aid groups, as well as U.S. contractors benefiting from the increased allocations. Looking ahead, future administrations may review these policies to balance local involvement with efficiency goals.
The analysis provides data that could inform congressional oversight or policy adjustments. No immediate changes to the funding model have been announced following the report's release.
Key Facts
Story Timeline
3 events- Recent
New analysis reveals Trump administration's foreign aid overhaul increased funding to U.S.-based contractors.
1 sourceThe New York Times - Trump Administration Period
Overhaul of foreign aid programs prioritized large U.S. contractors over developing world organizations.
1 sourceThe New York Times - Ongoing
U.S.-based nonprofit FHI360 operates nutrition programs in Borno, Nigeria, amid funding shifts.
1 sourceThe New York Times
Potential Impact
- 01
Local organizations in developing countries may face reduced capacity to deliver aid services.
- 02
U.S.-based contractors could expand operations with additional funding allocations.
- 03
Future U.S. aid policies might undergo review based on the analysis findings.
- 04
Communities in areas like Borno, Nigeria, continue receiving services through U.S. nonprofits.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…